Transmembrane Interactions of HIV-1 Vpu and Tetherin

被引:6
|
作者
Guo, Fei [2 ,3 ]
Liang, Chen [1 ,4 ]
机构
[1] McGill Univ, Lady Davis Inst, McGill AIDS Ctr, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[2] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China
[3] Peking Union Med Coll, Beijing 100730, Peoples R China
[4] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada
关键词
HIV; Vpu; tetherin; Nef; Envelope; CD4; transmembrane domain; NMR; HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-U VPU; TYPE-1; VPU; CYTOPLASMIC DOMAIN; DOWN-REGULATION; 3-DIMENSIONAL STRUCTURE; IN-VITRO; CD4; DEGRADATION; RELEASE;
D O I
10.2174/157016212800792450
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tetherin is a type II membrane protein that bears a N-terminal transmembrane domain, an extracellular coiled-coil structure and a C-terminal GPI anchor. This unique topology allows tetherin to block the release of a wide range of enveloped viruses from the cell surface. In order to overcome this host restriction, viruses have evolved various counter measures. In the case of human immunodeficiency virus type 1 (HIV-1), the viral protein U (Vpu) is able to down-modulate cell surface tetherin, thus removing tetherin molecules from the site of virus budding. This activity of Vpu depends on its direct interaction with tetherin. In this review, we summarize the known molecular details of the interaction between Vpu and tetherin, and also discuss how tetherin is targeted by other viral antagonists. Following our summary, it is evident that each of the intracellular, transmembrane and extracellular domains of tetherin can become the target of viral antagonists for counteraction.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 50 条
  • [21] Probing interactions of Vpu from HIV-1 with amiloride-based compounds
    Rosenberg, Matthew R.
    Weaver, Llara M.
    Casarotto, Marco G.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2016, 1858 (04): : 733 - 739
  • [22] Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance
    Kmiec, Dorota
    Iyer, Shilpa S.
    Stuerzel, Christina M.
    Sauter, Daniel
    Hahn, Beatrice H.
    Kirchhoff, Frank
    MBIO, 2016, 7 (04):
  • [23] β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release
    Tervo, Hanna-Mari
    Homann, Stefanie
    Ambiel, Ina
    Fritz, Joelle V.
    Fackler, Oliver T.
    Keppler, Oliver T.
    RETROVIROLOGY, 2011, 8
  • [24] Role of the Endosomal ESCRT Machinery in HIV-1 Vpu-Induced Down-Regulation of BST2/Tetherin
    Janvier, Katy
    Roy, Nicolas
    Berlioz-Torrent, Clarisse
    CURRENT HIV RESEARCH, 2012, 10 (04) : 315 - 320
  • [25] The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism
    Kuhl, Bjoern D.
    Cheng, Vicky
    Donahue, Daniel A.
    Sloan, Richard D.
    Liang, Chen
    Wilkinson, John
    Wainberg, Mark A.
    PLOS ONE, 2011, 6 (11):
  • [26] Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4+ T-cells is not directly related to the extent of tetherin cell surface downmodulation
    Kuhl, Bjoern D.
    Sloan, Richard D.
    Donahue, Daniel A.
    Liang, Chen
    Wainberg, Mark A.
    VIROLOGY, 2011, 417 (02) : 353 - 361
  • [27] Computational analysis of mutations in the transmembrane region of Vpu from HIV-1
    Candler, A
    Featherstone, M
    Ali, R
    Maloney, L
    Watts, A
    Fischer, WB
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1716 (01): : 1 - 10
  • [28] Lack of adaptation to human tetherin in HIV-1 Group O and P
    Yang, Su Jung
    Lopez, Lisa A.
    Exline, Colin M.
    Haworth, Kevin G.
    Cannon, Paula M.
    RETROVIROLOGY, 2011, 8
  • [29] BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: Evidence for a post-ER mechanism of Vpu-action
    Skasko, Mark
    Tokarev, Andrey
    Chen, Cheng-Chang
    Fischer, Wolfgang B.
    Pillai, Satish K.
    Guatelli, John
    VIROLOGY, 2011, 411 (01) : 65 - 77
  • [30] Mechanisms underlying HIV-1 Vpu-mediated viral egress
    Roy, Nicolas
    Pacini, Gregory
    Berlioz-Torrent, Clarisse
    Janvier, Katy
    FRONTIERS IN MICROBIOLOGY, 2014, 5